Volume 21, issue 6, August 2020
12 articles in this issue
-
-
Cost-effectiveness of a non-pharmacological treatment vs. “care as usual” in day care centers for community-dwelling older people with cognitive impairment: results from the German randomized controlled DeTaMAKS-trial
Authors (first, second and last of 4)
-
A novel method for predicting the budget impact of innovative medicines: validation study for oncolytics
Authors (first, second and last of 7)
-
-
-
Determination of the target population in early benefit assessments in Germany: challenges for non-small-cell lung cancer
Authors (first, second and last of 8)
-
A retrospective analysis of budget impact models submitted to the National Centre for Pharmacoeconomics in Ireland
Authors (first, second and last of 4)
-
Does linear equating improve prediction in mapping? Crosswalking MacNew onto EQ-5D-5L value sets
Authors
-
How expensive are post-traumatic stress disorders? Estimating incremental health care and economic costs on anonymised claims data
Authors (first, second and last of 4)
-
Budget impact of sequential treatment with first-line afatinib versus first-line osimertinib in non-small-cell lung cancer patients with common EGFR mutations
Authors (first, second and last of 7)
-
-
Lifetime cost of unilateral cochlear implants in adults: a Monte Carlo simulation
Authors (first, second and last of 4)
